Tweet
MORE THAN 465 MILLION DRAMS INVESTED BY VIVACELL-MTS IN EQUIPPING 34 MATERNITY HOSPITALS IN ARMENIA
YEREVAN, January 10. / ARKA /. VivaCell-MTS General Manager Ralph
Yirikian, BirthLink NGO Director Kathy Mellor and Dr. Pavel Mazmanyan,
the Chief Neonatologist of Armenia, visited neonatal departments
in Vedi and Artashat hospitals, Ararat region, which had received
equipment for immediate reanimation and warming of sick and small
babies, monitoring and management of respiratory difficulties and
delivering intravenous fluids.
"In the long-run, the neonatal care project is aimed at the reduction
of infant mortality in Armenia. And as an important step in this
direction is improved access to medical services in the regions. All
hospitals in the regions and capital Yerevan included in the project
have been provided with vital equipment and devices. The issue of
geographical access persists particularly in the regions, especially
those that are socially vulnerable and include the borderland
settlements. Too often, taking a newborn to the well-equipped hospital
in the capital to provide the necessary care can prove inefficient,
because of the loss of time. Project will result in drastic reduction
in the rate of transfers to hospitals in Yerevan, which is connected
to expenditures. People in the regions should have equal opportunities
to receive medical services, especially when it comes to infants,"
VivaCell-MTS General Manager Ralph Yirikian commented.
For the sixth year in a row VivaCell-MTS together with BirthLink NGO
makes efforts aimed at reducing the level of infant mortality in our
country. More than 465 million drams have already been invested by
VivaCell-MTS for equipping 34 maternity hospitals throughout Armenia -
12 in Yerevan and 22 in the marzes.
VivaCell-MTS is owned by Russian Mobile Telesystems (80 percent)
and Lebanse Fattouch Group (20%). ($1 - 408.09 drams). .-0-
- See more at:
http://arka.am/en/news/society/more_than_465_million_drams_invested_by_vivacell_m ts_in_equipping_34_maternity_hospitals_in_armenia_/#sthash.UCjd2C9C.dpuf
YEREVAN, January 10. / ARKA /. VivaCell-MTS General Manager Ralph
Yirikian, BirthLink NGO Director Kathy Mellor and Dr. Pavel Mazmanyan,
the Chief Neonatologist of Armenia, visited neonatal departments
in Vedi and Artashat hospitals, Ararat region, which had received
equipment for immediate reanimation and warming of sick and small
babies, monitoring and management of respiratory difficulties and
delivering intravenous fluids.
"In the long-run, the neonatal care project is aimed at the reduction
of infant mortality in Armenia. And as an important step in this
direction is improved access to medical services in the regions. All
hospitals in the regions and capital Yerevan included in the project
have been provided with vital equipment and devices. The issue of
geographical access persists particularly in the regions, especially
those that are socially vulnerable and include the borderland
settlements. Too often, taking a newborn to the well-equipped hospital
in the capital to provide the necessary care can prove inefficient,
because of the loss of time. Project will result in drastic reduction
in the rate of transfers to hospitals in Yerevan, which is connected
to expenditures. People in the regions should have equal opportunities
to receive medical services, especially when it comes to infants,"
VivaCell-MTS General Manager Ralph Yirikian commented.
For the sixth year in a row VivaCell-MTS together with BirthLink NGO
makes efforts aimed at reducing the level of infant mortality in our
country. More than 465 million drams have already been invested by
VivaCell-MTS for equipping 34 maternity hospitals throughout Armenia -
12 in Yerevan and 22 in the marzes.
VivaCell-MTS is owned by Russian Mobile Telesystems (80 percent)
and Lebanse Fattouch Group (20%). ($1 - 408.09 drams). .-0-
- See more at:
http://arka.am/en/news/society/more_than_465_million_drams_invested_by_vivacell_m ts_in_equipping_34_maternity_hospitals_in_armenia_/#sthash.UCjd2C9C.dpuf